Get
Noticed
HERE

Ask Pharma Compass

Free Demo Request

Global Pharmaceutical Intelligence

Smarter Sourcing, Faster Drug Launches, Quicker Business Leads, Killer Sales

    NEWS & ALERTS

    TOP 10 NEWS OF THE DAY

    NEWS LIBRARY

    Recent Approvals

    Compliance Alerts

    MARKET PLACE

    ENQUIRIES FOR APIs

    Post an enquiry PharmaCompass.com

    A pharmaceutical company based in Chandigarh, India is searching for following products for domestic consumption:
    1. Gabapentin 25 kg
    2. Torsemide 5 kg
    3. Clobazam 1 kg
    4. Chlordiazepoxide PI 2 Kg
    5. Clidinium Bromide 1 kg

    Comments

    A leader in the trade of Specialized Chemicals and Raw materials for food, detergent, and pharmaceutical industry in Jordan is searching for suppliers of Fluorometholone (micronized less than 15 µm) API for one of their clients.

    Comments

    A well established Egyptian Pharmaceutical company is searching for suppliers of Canagliflozin, Sacubitril-Valsartan and Saxagliptin APIs for domestic consumption. The current requirement is for commercial quantities. The suppliers/manufacturers must support the products with GMP certificate.

    Comments (5)

    ENQUIRIES FOR FINISHED FORMULATIONS

    Crescent Chemist in Ghana is searching for suppliers of Praziquantel 500 mg tablets (5000 units). Interested suppliers/manufacturers should contact Abdul Yaro via Email: abdulrazak2002gh@yahoo.com or Tel: 07886947245.

    Comments

    Auramedi, a new Brazilian Pharma Company, an enterprise devoted to bringing to prescribers and customers new concepts related to treatment for health and well being is searching for suppliers of Mesalazine modified release 500 mg tablets for distribution in the country. The current requirement is for 3,000,000 to 5,000,000 tablets per year. The suppliers/manufacturers must support the product with following documents:
    1. e-CTD format dossier
    2. Certificate of Good Manufacture Practices issued by ANVISA
    3. All the requirements to registration in ANVISA.
    4. Price submission at CMED (Price Medication Chamber)
    Interested suppliers should contact Edson Brito via Email: edson.brito@auramedi.com or Tel: +55 11 95116 8601.

    Comments

    A privately held emerging specialty pharmaceutical company dedicated to the development and commercialization of innovative late-stage therapies is looking for an injectable company that can fill pre-filled syringe (PFS) in nested trays for USA market. The President of the company will be attending CPhI Worldwide in Frankfurt and would be happy to meet interested contract manufacturers.

    Comments (2)

    FEATURED COMPANIES

    PARTIAL LIST OF PARTNER COMPANIES

    BLOG & ANALYSIS

    RADIO BLOG

    Dead fish in Hyderabad puts pharma majors under scrutiny; False data uncovered in AstraZeneca’s US$ 4 billion buy

    Dead fish in Hyderabad puts pharma majors under scrutiny; False data uncovered in AstraZeneca’s US$ 4 billion buy

    This week, Phispers has news from across the world. While China is trying to speed up approval of dr...

    Radio Compass

    PharmaCompass.com

    Biocon now in data integrity net; Chinese money on lookout for generic firms

    Biocon now in data integrity net; Chinese money on lookout for generic firms

    This week, Phispers brings you more bad news from India’s Biocon, as Health Canada’s cau...

    Radio Compass

    PharmaCompass.com

    Re-inspection of Divi’s Vizag unit indicates a long haul ahead

    Re-inspection of Divi’s Vizag unit indicates a long haul ahead

    In March this year, PharmaCompass had shared the observations made by the US Food and Drug Administr...

    Radio Compass

    PharmaCompass.com

    RADIO DATA

    Pharma Deals / Investments / M&As in Aug 2017

    Pharma Deals / Investments / M&As in Aug 2017

    cGMP Non-Compliances in 2017 (Jan-July)

    cGMP Non-Compliances in 2017 (Jan-July)

    Active Pharmaceutical Ingredient Drug Master Files (DMFs) Submitted to the U.S. FDA in Q4 2016 & Q1 2017

    Active Pharmaceutical Ingredient Drug Master Files (DMFs) Submitted to the U.S. FDA in Q4 2016 & Q1 2017